| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
U2Bio Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩3,925.00 |
| 52 Week High | ₩10,950.00 |
| 52 Week Low | ₩3,720.00 |
| Beta | 0 |
| 1 Month Change | -12.78% |
| 3 Month Change | -23.79% |
| 1 Year Change | -40.35% |
| 3 Year Change | 36.52% |
| 5 Year Change | 0.64% |
| Change since IPO | -1.26% |
Recent News & Updates
Recent updates
Shareholder Returns
| A221800 | KR Healthcare | KR Market | |
|---|---|---|---|
| 7D | 1.9% | -1.1% | -3.0% |
| 1Y | -40.3% | 12.8% | 0.6% |
Return vs Industry: A221800 underperformed the KR Healthcare industry which returned 12.8% over the past year.
Return vs Market: A221800 underperformed the KR Market which returned 0.6% over the past year.
Price Volatility
| A221800 volatility | |
|---|---|
| A221800 Average Weekly Movement | 7.3% |
| Healthcare Industry Average Movement | 5.8% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 12.0% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A221800's share price has been volatile over the past 3 months.
Volatility Over Time: A221800's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2009 | n/a | Jin-Tae Kim | www.u2bio.co.kr |
U2Bio Co., Ltd. provides healthcare services in South Korea. The company also offers clinical laboratory test services; digital healthcare services related to testing and health examinations; and bio-technology platforms. The company was founded in 2009 and is headquartered in Seoul, South Korea.
U2Bio Co., Ltd. Fundamentals Summary
| A221800 fundamental statistics | |
|---|---|
| Market cap | ₩44.30b |
| Earnings (TTM) | ₩0 |
| Revenue (TTM) | n/a |
n/a
P/E Ration/a
P/S RatioIs A221800 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A221800 income statement (TTM) | |
|---|---|
| Revenue | ₩0 |
| Cost of Revenue | ₩0 |
| Gross Profit | ₩0 |
| Other Expenses | ₩0 |
| Earnings | ₩0 |
Last Reported Earnings
n/a
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did A221800 perform over the long term?
See historical performance and comparison